THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | 0.0% | 215 | 0.0% | 0.00% | – |
Q2 2023 | $2 | 0.0% | 215 | 0.0% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 215 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.9% | 215 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 215 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 215 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 215 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 215 | +79.2% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 120 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 120 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 120 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | -60.0% | 120 | -65.5% | 0.00% | – |
Q3 2020 | $5,000 | -84.4% | 348 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $32,000 | +300.0% | 348 | 0.0% | 0.00% | – |
Q1 2020 | $8,000 | +14.3% | 348 | +8.8% | 0.00% | – |
Q4 2019 | $7,000 | 0.0% | 320 | -9.3% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 353 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | -25.0% | 353 | 0.0% | 0.00% | – |
Q1 2019 | $8,000 | -20.0% | 353 | +18.1% | 0.00% | – |
Q3 2018 | $10,000 | +42.9% | 299 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | 0.0% | 299 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | – | 299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |